- Antidiabetic Agents and Bone Quality: A Focus on Glycation End Products and Incretin Pathway Modulations
-
Zaki MK, Abed MN, Alassaf FA
- KMID: 2558954
- J Bone Metab.
- 2024 Aug;31(3):169-181.
- doi: 10.11005/jbm.2024.31.3.169
Diabetes mellitus is associated with inadequate bone health and quality and heightened susceptibility to fractures, even in patients with normal or elevated bone mineral density. Elevated advanced glycation end-products (AGEs)... -
- CITED
-
- Close
- SHARE
-
- Close
